REPORT ID 7135

Global Double Barreled Antibodies Drug Market Research Report 2017

Publish Date
2-Nov-17
Pages
110
Format
Electronic (PDF)

In this report, the global Double Barreled Antibodies Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Double Barreled Antibodies Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Double Barreled Antibodies Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Amgen Inc.
    F. Hoffman La Roche Ltd.
    AbbVie Inc.
    OncoMed Pharmaceuticals, Inc.
    Glenmark Pharmaceuticals Limited
    Xencor, Inc.
    MacroGenics, Inc.
    Aptevo Therapeutics Inc.
    Ligand Pharmaceuticals, Inc.
    Regeneron Pharmaceuticals, Inc.
    Fresenius SE & Co. KGaA
    Merus N.V.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Removab
    BLINCYTO
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Lung Cancer
    Brain Cancer
    Liver Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Double Barreled Antibodies Drug Market Research Report 2017
1 Double Barreled Antibodies Drug Market Overview
    1.1 Product Overview and Scope of Double Barreled Antibodies Drug
    1.2 Double Barreled Antibodies Drug Segment by Type (Product Category)
        1.2.1 Global Double Barreled Antibodies Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Double Barreled Antibodies Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 Removab
        1.2.4 BLINCYTO
        1.2.5 Others
    1.3 Global Double Barreled Antibodies Drug Segment by Application
        1.3.1 Double Barreled Antibodies Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Lung Cancer
        1.3.3 Brain Cancer
        1.3.4 Liver Cancer
        1.3.5 Others
    1.4 Global Double Barreled Antibodies Drug Market by Region (2012-2022)
        1.4.1 Global Double Barreled Antibodies Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Double Barreled Antibodies Drug (2012-2022)
        1.5.1 Global Double Barreled Antibodies Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Double Barreled Antibodies Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Double Barreled Antibodies Drug Market Competition by Manufacturers
    2.1 Global Double Barreled Antibodies Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Double Barreled Antibodies Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Double Barreled Antibodies Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Double Barreled Antibodies Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Double Barreled Antibodies Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Double Barreled Antibodies Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Double Barreled Antibodies Drug Market Competitive Situation and Trends
        2.5.1 Double Barreled Antibodies Drug Market Concentration Rate
        2.5.2 Double Barreled Antibodies Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Double Barreled Antibodies Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Double Barreled Antibodies Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Double Barreled Antibodies Drug Production and Market Share by Region (2012-2017)
    3.3 Global Double Barreled Antibodies Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Double Barreled Antibodies Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Double Barreled Antibodies Drug Consumption by Region (2012-2017)
    4.2 North America Double Barreled Antibodies Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Double Barreled Antibodies Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Double Barreled Antibodies Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Double Barreled Antibodies Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Double Barreled Antibodies Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Double Barreled Antibodies Drug Production, Consumption, Export, Import (2012-2017)

5 Global Double Barreled Antibodies Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Double Barreled Antibodies Drug Production and Market Share by Type (2012-2017)
    5.2 Global Double Barreled Antibodies Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Double Barreled Antibodies Drug Price by Type (2012-2017)
    5.4 Global Double Barreled Antibodies Drug Production Growth by Type (2012-2017)

6 Global Double Barreled Antibodies Drug Market Analysis by Application
    6.1 Global Double Barreled Antibodies Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Double Barreled Antibodies Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Double Barreled Antibodies Drug Manufacturers Profiles/Analysis
    7.1 Amgen Inc.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Amgen Inc. Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 F. Hoffman La Roche Ltd.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 AbbVie Inc.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 AbbVie Inc. Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 OncoMed Pharmaceuticals, Inc.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Glenmark Pharmaceuticals Limited
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Xencor, Inc.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Xencor, Inc. Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 MacroGenics, Inc.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 MacroGenics, Inc. Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Aptevo Therapeutics Inc.
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Ligand Pharmaceuticals, Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Regeneron Pharmaceuticals, Inc.
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Fresenius SE & Co. KGaA
    7.12 Merus N.V.

8 Double Barreled Antibodies Drug Manufacturing Cost Analysis
    8.1 Double Barreled Antibodies Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Double Barreled Antibodies Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Double Barreled Antibodies Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Double Barreled Antibodies Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Double Barreled Antibodies Drug Market Forecast (2017-2022)
    12.1 Global Double Barreled Antibodies Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Double Barreled Antibodies Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Double Barreled Antibodies Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Double Barreled Antibodies Drug Price and Trend Forecast (2017-2022)
    12.2 Global Double Barreled Antibodies Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Double Barreled Antibodies Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Double Barreled Antibodies Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Double Barreled Antibodies Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Double Barreled Antibodies Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Double Barreled Antibodies Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Double Barreled Antibodies Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Double Barreled Antibodies Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Double Barreled Antibodies Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer